170 results
DFAN14A
SLGCW
SomaLogic, Inc.
4 Jan 24
Additional proxy materials by non-management
10:49am
the benefits of the proposed combination with Standard
BioTools, and on the right side it gives the company’s
version of the “Independent
DEFA14A
SLGCW
SomaLogic, Inc.
2 Jan 24
Additional proxy soliciting materials
9:43pm
the significant financial and strategic benefits of the transaction, and the facts behind the comprehensive strategic alternatives process … the anticipated benefits from the merger or cause the parties to abandon the merger; (xi) risks that the anticipated benefits of the merger or other
DEFA14A
SLGCW
SomaLogic, Inc.
2 Jan 24
Additional proxy soliciting materials
5:05pm
SomaLogic stockholders vote “FOR” the pending transaction.
Benefits of Combination with Standard BioTools
Accelerates path to profitability and value … business.
Realize the Compelling Benefits of the Proposed Merger Between SomaLogic and Standard BioTools While Protecting the Value of Your Investment
8-K
EX-99.1
SLGCW
SomaLogic, Inc.
2 Jan 24
SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting “FOR” Pending Merger with Standard BioTools
5:04pm
Services (“ISS”) and Glass Lewis, recommending SomaLogic stockholders vote “FOR” the pending transaction.
Benefits of Combination with Standard … also mitigating risks and challenges inherent in SomaLogic’s business.
Realize the Compelling Benefits of the Proposed Merger Between SomaLogic
8-K
SLGCW
SomaLogic, Inc.
2 Jan 24
SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting “FOR” Pending Merger with Standard BioTools
5:04pm
and regulatory approvals may delay the consummation of the Merger or result in the imposition of conditions that could reduce the anticipated benefits from … the Merger or cause the parties to abandon the Merger; (xi) risks that the anticipated benefits of the Merger or other commercial opportunities may
DEFA14A
b021 1r7cw6jwv67
29 Dec 23
Additional proxy soliciting materials
5:30pm
8-K
6reb6r6ukoxbn8u55vwc
29 Dec 23
Leading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
5:29pm
8-K
EX-99.1
0tjtl8yz3p0n
29 Dec 23
Leading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
5:29pm
425
zo3 fhq0zexnc
29 Dec 23
Business combination disclosure
5:26pm
425
EX-99.1
0wuqrs8 g0lmha
29 Dec 23
Business combination disclosure
5:26pm
DEFA14A
wu1o 1boqwx04
29 Dec 23
Additional proxy soliciting materials
4:21pm
8-K
EX-99.1
tb2y2hfj11p 4c7d2ll0
29 Dec 23
Regulation FD Disclosure
4:19pm
8-K
6kn2tdkz
29 Dec 23
Regulation FD Disclosure
4:19pm
425
EX-99.1
o1ck3l58zqizee
26 Dec 23
Business combination disclosure
5:11pm
425
ccrne4 wllzmg
26 Dec 23
Business combination disclosure
5:11pm
8-K
EX-99.1
c5xbf5k05fhh
26 Dec 23
SomaLogic Issues Statement Correcting Madryn Asset Management’s Misleading Disclosure
5:10pm
8-K
4in4nlf
26 Dec 23
SomaLogic Issues Statement Correcting Madryn Asset Management’s Misleading Disclosure
5:10pm
425
tjjzqboga6fr0yn
22 Dec 23
Business combination disclosure
9:45pm
425
EX-99.1
ykxfmbzxa9dwul
22 Dec 23
Business combination disclosure
9:45pm
8-K
EX-99.1
hy53yx8csz2kld3g
22 Dec 23
ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
9:43pm